Clinical Trial Update: Sunitinib in Treating Young Patients With Refractory Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sunitinib in pediatric patients with refractory solid tumors, including various childhood central nervous system tumors, has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Metastases
• Childhood Central Nervous System Choriocarcinoma
• Childhood Central Nervous System Embryonal Tumor
• Childhood Central Nervous System Germ Cell Tumor
• Childhood Central Nervous System Germinoma
• Childhood Central Nervous System Teratoma
• Childhood Central Nervous System Yolk Sac Tumor

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Central Nervous System Metastases, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Status: COMPLETED